Ryan M, Johnson MS: Use of alternative medications in patients with neurologic disorders. Ann Pharmacother 2002, 36:1540–1545.
Pearl PL, Robbins EL, Bennett BA, Conry JA: Use of complementary and alternative therapies in epilepsy. Arch Neurol 2005, 62:1472–1475.
Cohen MH: Regulation, religious experience, and epilepsy: a lens on complementary therapies. Epilepsy Behav 2003, 4:602–606.
Barnes P, Powell-Griner E, McFann K, Nahin R: CDC advance data report 343: The use of complementary and alternative medicine in the United States. National Institutes of Health, US Department of Health and Human Services; 2004.
Thompson PJ, O’Toole A: Psychosocial outcome. In Epilepsy 2003: From Synapse to Society. Edited by Sander JW, Walker MC, Smalls JE: National Society for Epilepsy; 2003:524.
Kwan P, Brodie MJ: Early identification of refractory epilepsy. N Engl J Med 2000, 342:314–319.
Sisodiya SM: Genetics of drug resistance in epilepsy. Curr Neurol Neurosci Rep 2005, 5:307–311.
Sirven JI, Drazkowski JF, Zimmerman RS, et al.: Complementary/ alternative medicine for epilepsy in Arizona. Neurology 2003, 61:576–577.
Gross-Tsur V, Lahad A, Shalev RS: Use of complementary medicine in children with attention deficit hyperactivity disorder and epilepsy. Pediatric Neurology 2003, 29:53–55.
Peebles CT, McAuley JW, Roach J, et al.: Alternative medicine use by patients with epilepsy. Epilepsy Behav 2000, 1:74–77.
Shang A, Huwiler-Muntener K, Nartey L, et al.: Are the clinical effects of homoeopathy placebo effects? Comparative study of placebo-controlled trials of homoeopathy and allopathy. Lancet 2005, 366:726–732.
SAHOP: Open letter to the editor of The Lancet. Forsch Komplementarmed Klass Naturheilkd 2005, 12:352–353.
Declaration of the Liga Medicorum Homeopathica Internationalis. http://www.svha.ch. Accessed February 22, 2006.
Hodiamont G: Trattato di Farmacologie Ameopatica: Nuova IPSA; 2004.
Tandon M, Prabhakar S, Pandhi P: Pattern of use of complementary/ alternative medicine (CAM) in epileptic patients in a tertiary care hospital in India. Pharmacoepidemiol Drug Saf 2002, 11:457–463.
Vermuelen F: Concordant Materia Medica edn 3. Haarlem, The Netherlands: Emryss; 2003.
Tyagi A, Delanty N: Herbal remedies, dietary supplements, and seizures. Epilepsia 2003, 44:228–235. This paper is a comprehensive and balanced review of the use of herbal remedies, highlighting those that are useful as well as mentioning practical important issues for clinicians on drug interactions.
Ramamurthi B, Gurunathan SK: Epilepsy in ayurveda. Neurol India 1969, 17:91–93.
Chen LC, Chen YF, Yang LL, et al.: Drug utilization pattern of antiepileptic drugs and traditional Chinese medicines in a general hospital in Taiwan—a pharmaco-epidemiologic study. J Clin Pharm Ther 2000, 25:125–129.
Lai CW, Lai YH: History of epilepsy in Chinese traditional medicine. Epilepsia 1991, 32:299–302.
Sibley V: Aromatherapy Solutions, edn 1. London: Hamlyn; 2004.
Bailey CH, Giustetto M, Huang YY, et al.: Is heterosynaptic modulation essential for stabilizing Hebbian plasticity and memory? Nat Rev Neurosci 2000, 1:11–20.
Efron R: The conditioned inhibition of uncinate fits. Brain 1957, 80:251–261.
Betts T: Use of aromatherapy (with or without hypnosis) in the treatment of intractable epilepsy—a two-year follow-up study. Seizure 2003, 12:534–538.
Kumar AR, Kurup PA: Changes in the isoprenoid pathway with transcendental meditation and Reiki healing practices in seizure disorder. Neurol India 2003, 51:211–214.
Yardi N: Yoga for control of epilepsy. Seizure 2001, 10:7–12. Yoga and its effects on brain activity are presented in a clear, concise manner by the authors. The potential neurophysiologic effects in seizure control are also discussed.
Pistolese RA: Epilepsy and seizure disorders: a review of literature relative to chiropractic care of children. J Manipulative Physiol Ther 2001, 24:199–205.
Vining EP, Freeman JM, Ballaban-Gil K, et al.: A multicenter study of the efficacy of the ketogenic diet. Arch Neurol 1998, 55:1433–1437.
Kang HC, Chung da E, Kim DW, Kim HD: Early- and lateonset complications of the ketogenic diet for intractable epilepsy. Epilepsia 2004, 45:1116–1123.
Kossoff EH, McGrogan JR, Bluml RM, et al.: A modified Atkins diet is effective for the treatment of intractable paediatric epilepsy. Epilepsia 2006, 47:421–424.
Pfeifer HH, Thiele EA: Low-glycemic-index treatment: a liberalized ketogenic diet for treatment of intractable epilepsy. Neurology 2005, 65:1810–1812.